Clinical trial

Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD

NCT05607719

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-04-11

PhasePHASE2

Study timeline

Study start (actual)2023-04-11Date precision: day

Registry last updated2026-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Interventions

BevespiDRUG · verified · RxNorm: Bevespi

BretzriDRUG

Sponsors & collaborators

University of Miamilead sponsor

AstraZenecacollaborator

Mapped research locations

MiamiFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05607719 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.